{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:41:16Z","timestamp":1790642476346,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases of the National Institutes of Health","award":["R01 AI119446"],"award-info":[{"award-number":["R01 AI119446"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.cmi.2017.12.004","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T07:40:23Z","timestamp":1513582823000},"page":"689-696","source":"Crossref","is-referenced-by-count":36,"title":["Assessment and modelling of antibacterial combination regimens"],"prefix":"10.1016","volume":"24","author":[{"given":"G.G.","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Garonzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Nation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.12.004_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fmicb.2013.00047","article-title":"The multifaceted roles of antibiotics and antibiotic resistance in nature","volume":"4","author":"Sengupta","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2017.12.004_bib2","series-title":"Office of infectious disease antibiotic resistance threats in the United States","author":"CDC","year":"2013"},{"key":"10.1016\/j.cmi.2017.12.004_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","article-title":"Emergence and spread of antibiotic resistance following exposure to antibiotics","volume":"35","author":"Canton","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.cmi.2017.12.004_bib4","series-title":"Antimicrobial resistance: global report on surveillance","author":"WHO","year":"2014"},{"key":"10.1016\/j.cmi.2017.12.004_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/0972-5229.132495","article-title":"Current concepts in combination antibiotic therapy for critically ill patients","volume":"18","author":"Ahmed","year":"2014","journal-title":"Ind J Crit Care Med"},{"key":"10.1016\/j.cmi.2017.12.004_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13054-016-1320-7","article-title":"Antibiotic strategies in the era of multidrug resistance","volume":"20","author":"Karam","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2017.12.004_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/03009734.2014.899279","article-title":"Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria","volume":"119","author":"T\u00e4ngd\u00e9n","year":"2014","journal-title":"Uppsala J Med Sci"},{"key":"10.1016\/j.cmi.2017.12.004_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.molmed.2007.04.004","article-title":"New strategies for combating multidrug-resistant bacteria","volume":"13","author":"Wright","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cmi.2017.12.004_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ja.2013.49","article-title":"Prospects for new antibiotics: a molecule-centered perspective","volume":"67","author":"Walsh","year":"2014","journal-title":"J\u00a0Antibiot (Tokyo)"},{"key":"10.1016\/j.cmi.2017.12.004_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(83)90088-8","article-title":"Rationale for use of antimicrobial combinations","volume":"75","author":"Moellering","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2017.12.004_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2017.12.004_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cmi.2017.12.004_bib13","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nrd2424","article-title":"The design of drugs for HIV and HCV","volume":"6","author":"De Clercq","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cmi.2017.12.004_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002380","article-title":"Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria?","volume":"14","author":"Hemingway","year":"2016","journal-title":"PLOS Biol"},{"issue":"7458","key":"10.1016\/j.cmi.2017.12.004_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/499291a","article-title":"Cancer: calculated treatment","volume":"499","author":"Komarova","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2017.12.004_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrd2195","article-title":"A\u00a0robustness-based approach to systems-oriented drug design","volume":"6","author":"Kitano","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cmi.2017.12.004_bib17","first-page":"7","article-title":"Systems biology approaches for advancing the discovery of effective drug combinations","volume":"7","author":"Ryall","year":"2015","journal-title":"J\u00a0Cheminform"},{"key":"10.1016\/j.cmi.2017.12.004_bib18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1535-7163.MCT-06-0084","article-title":"Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases","volume":"5","author":"Smalley","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"205","key":"10.1016\/j.cmi.2017.12.004_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006667","article-title":"High-throughput methods for combinatorial drug discovery","volume":"5","author":"Sun","year":"2013","journal-title":"Sci Translat Med"},{"key":"10.1016\/j.cmi.2017.12.004_bib20","series-title":"Systems pharmacology and pharmacodynamics","first-page":"371","article-title":"Translational modeling of antibacterial agents","author":"Rao","year":"2016"},{"key":"10.1016\/j.cmi.2017.12.004_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.prrv.2007.04.006","article-title":"Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'","volume":"8","author":"Saiman","year":"2007","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.cmi.2017.12.004_bib22","first-page":"5318","article-title":"Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-\u03b2-d-arabinofuranosylcytosine","volume":"50","author":"Greco","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.cmi.2017.12.004_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"10.1016\/j.cmi.2017.12.004_bib24","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.cmi.2017.12.004_bib25","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/AAC.00092-13","article-title":"Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design","volume":"57","author":"Landersdorfer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.12.004_bib26","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1128\/AAC.48.6.2061-2068.2004","article-title":"Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin","volume":"48","author":"Meagher","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.12.004_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/AAC.00489-08","article-title":"Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa","volume":"53","author":"Bulitta","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.12.004_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10928-004-8319-4","article-title":"Assessment of drug interactions relevant to pharmacodynamic indirect response models","volume":"31","author":"Earp","year":"2004","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.cmi.2017.12.004_bib29","unstructured":"Okusany OOFA, Bulik CC, Bhavnani SM, Ambrose PG, Zhu T, Drusano GL, et\u00a0al. Pharmacokinetic-pharmacodynamic analyses for rifampin in combination with sutezolid or linezolid against Mycobacterium tuberculosis in log-phase using data from a hollow-fiber infection model. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 10\u201313, 2013; Denver, Colorado."},{"key":"10.1016\/j.cmi.2017.12.004_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1365-2958.2006.05453.x","article-title":"Integration of omics data: how well does it work for bacteria?","volume":"62","author":"De Keersmaecker","year":"2006","journal-title":"Mol Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17306778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17306778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T02:19:04Z","timestamp":1561947544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17306778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1198743X17306778"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.12.004","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}